Basit öğe kaydını göster

dc.contributor.authorYazici, Omer Kemal
dc.contributor.authorBenekli, Mustafa
dc.contributor.authorIsikdogan, Abdurrahman
dc.contributor.authorUrakci, Zuhat
dc.contributor.authorBalakan, Ozan
dc.contributor.authorAyyildiz, Orhan
dc.contributor.authorMehmet, Kucukoner
dc.contributor.authorSener, Cihan
dc.contributor.authorUyeturk, Ummugul
dc.contributor.authorSeker, Mesut
dc.contributor.authorTastekin, Didem
dc.contributor.authorTonyali, Onder
dc.contributor.authorOksuzoglu, Berna
dc.contributor.authorBoruban, Melih Cem
dc.contributor.authorGumus, Mahmut
dc.contributor.authorUncu, Dogan
dc.contributor.authorDal, Sinan
dc.contributor.authorSuner, Ali
dc.contributor.authorKaplan, Muhammed Ali
dc.contributor.authorInal, Ali
dc.contributor.authorOzdemir, Nuriye
dc.date.accessioned2021-03-02T22:18:41Z
dc.date.available2021-03-02T22:18:41Z
dc.date.issued2014
dc.identifier.citationMehmet K., Sener C., Uyeturk U., Seker M., Tastekin D., Tonyali O., Balakan O., Yazici O. K. , Urakci Z., Isikdogan A., et al., "Treatment modalities in primary gastric lymphoma: the effect of rituximab and surgical treatment. A study by the Anatolian Society of Medical Oncology", WSPOLCZESNA ONKOLOGIA-CONTEMPORARY ONCOLOGY, cilt.18, sa.4, ss.273-278, 2014
dc.identifier.otherav_0bfb207c-6fe5-4231-b017-56a59a410929
dc.identifier.othervv_1032021
dc.identifier.urihttp://hdl.handle.net/20.500.12627/13713
dc.identifier.urihttps://doi.org/10.5114/wo.2014.40556
dc.description.abstractAim of the study: Gastrointestinal lymphoma is the most common type of extranodal lymphoma and commonly involved site is the stomach. We have compared the superiority between treatment modalities for primary gastric lymphoma and we want to investigate efficacy of rituximab in gastric lymphoma.
dc.language.isoeng
dc.subjectDahili Tıp Bilimleri
dc.subjectOnkoloji
dc.subjectİç Hastalıkları
dc.subjectONKOLOJİ
dc.subjectKlinik Tıp
dc.subjectKlinik Tıp (MED)
dc.subjectTıp
dc.subjectSağlık Bilimleri
dc.titleTreatment modalities in primary gastric lymphoma: the effect of rituximab and surgical treatment. A study by the Anatolian Society of Medical Oncology
dc.typeMakale
dc.relation.journalWSPOLCZESNA ONKOLOGIA-CONTEMPORARY ONCOLOGY
dc.contributor.departmentDicle Üniversitesi , ,
dc.identifier.volume18
dc.identifier.issue4
dc.identifier.startpage273
dc.identifier.endpage278
dc.contributor.firstauthorID2358647


Bu öğenin dosyaları:

DosyalarBoyutBiçimGöster

Bu öğe ile ilişkili dosya yok.

Bu öğe aşağıdaki koleksiyon(lar)da görünmektedir.

Basit öğe kaydını göster